{"id":6129,"date":"2026-08-26T12:56:26","date_gmt":"2026-08-26T12:56:26","guid":{"rendered":"https:\/\/indiangenericmedicines.com\/?post_type=product&p=6129"},"modified":"2026-09-03T13:38:48","modified_gmt":"2026-09-03T13:38:48","slug":"tislelizumab","status":"publish","type":"product","link":"https:\/\/indiangenericmedicines.com\/zh\/oncology\/tislelizumab\/","title":{"rendered":"Tislelizumab Injection"},"content":{"rendered":"

Tislelizumab Injection<\/strong> is a PD-1 inhibitor and humanised monoclonal antibody used in specific cancer-treatment regimens. It works by blocking the PD-1 pathway, helping restore immune-system activity against cancer cells. Tislelizumab is administered by intravenous infusion, with the current EU product information specifying a 100 mg\/10 mL concentrate for solution for infusion. Availability, presentation and approved uses may vary by market and product.<\/p>\n

What Is Tislelizumab?<\/h2>\n

Tislelizumab is a humanised monoclonal antibody that targets programmed cell death protein 1 (PD-1), an immune checkpoint receptor found on immune cells. By binding to PD-1, Tislelizumab helps prevent interactions with its ligands PD-L1 and PD-L2. This can reduce the immune-suppressive signalling that allows cancer cells to avoid immune-system activity.<\/p>\n

Tislelizumab is used as part of specific oncology treatment regimens and is administered through intravenous infusion under the supervision of qualified healthcare professionals.<\/p>\n

What Is Tislelizumab Used For?<\/h2>\n

Tislelizumab is used in specific cancer treatment settings. The appropriate indication depends on the cancer type, disease stage, biomarker status, previous treatment and the applicable product label.<\/p>\n

Tislelizumab for Non-Small Cell Lung Cancer<\/h3>\n

Tislelizumab may be used in specified treatment regimens for adults with certain types and stages of non-small cell lung cancer (NSCLC).<\/p>\n

Tislelizumab for Small Cell Lung Cancer<\/h3>\n

Tislelizumab is also authorised in specific treatment settings for adults with extensive-stage small cell lung cancer, according to applicable product information.<\/p>\n

Tislelizumab for Gastric and Gastroesophageal Junction Cancer<\/h3>\n

In selected patients with unresectable, locally advanced or metastatic gastric or gastroesophageal junction adenocarcinoma, Tislelizumab may be used in combination with chemotherapy according to the applicable indication.<\/p>\n

Tislelizumab for Oesophageal Squamous Cell Carcinoma<\/h3>\n

Tislelizumab is used in certain treatment settings for advanced or metastatic oesophageal squamous cell carcinoma.<\/p>\n

Tislelizumab for Nasopharyngeal Carcinoma<\/h3>\n

Tislelizumab may also be used for specific treatment settings involving recurrent, locally advanced or metastatic nasopharyngeal carcinoma.<\/p>\n

Note:<\/strong> Approved indications and treatment combinations may vary by country and regulatory authority. Treatment should always follow the current prescribing information applicable to the patient’s market.<\/p>\n

How Does Tislelizumab Work?<\/h2>\n

Tislelizumab works by targeting the PD-1 immune checkpoint pathway<\/strong>.<\/p>\n

Cancer cells can use PD-L1 and PD-L2 signalling to reduce the activity of immune cells. Tislelizumab binds to PD-1 and blocks its interaction with PD-L1 and PD-L2. This can help restore immune-cell activity and support the body’s immune response against tumour cells.<\/p>\n

Tislelizumab is therefore classified as a PD-1 inhibitor<\/strong> and belongs to the broader group of cancer immunotherapies.<\/p>\n

Tislelizumab Injection Administration<\/h2>\n

Tislelizumab is administered as an intravenous infusion<\/strong> by qualified healthcare professionals.<\/p>\n

The dosage and treatment schedule depend on factors such as:<\/p>\n

    \n
  • The specific cancer being treated<\/li>\n
  • Treatment regimen<\/li>\n
  • Previous therapy<\/li>\n
  • Patient-specific factors<\/li>\n
  • Applicable product information<\/li>\n<\/ul>\n

    Tislelizumab may be administered alone or in combination with other anticancer medicines where specifically indicated.<\/p>\n

    Patients should not determine or change the dose or treatment schedule themselves.<\/strong><\/p>\n

    Tislelizumab Storage and Handling<\/h2>\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    Parameter<\/th>\nDetails<\/th>\n<\/tr>\n<\/thead>\n
    Storage Temperature<\/strong><\/td>\n2\u00b0C to 8\u00b0C<\/td>\n<\/tr>\n
    Freezing<\/strong><\/td>\nDo not freeze<\/td>\n<\/tr>\n
    Light Protection<\/strong><\/td>\nKeep the vial in the outer carton<\/td>\n<\/tr>\n
    Container<\/strong><\/td>\nOriginal vial<\/td>\n<\/tr>\n
    Diluted Solution<\/strong><\/td>\nHandle according to the applicable product information<\/td>\n<\/tr>\n
    Transportation<\/strong><\/td>\nMaintain required temperature-controlled conditions where applicable<\/td>\n<\/tr>\n
    Handling<\/strong><\/td>\nFollow appropriate aseptic preparation and administration procedures<\/td>\n<\/tr>\n
    Before Administration<\/strong><\/td>\nCheck the current product information for preparation and in-use requirements<\/td>\n<\/tr>\n
    Important<\/strong><\/td>\nStorage and handling requirements may vary by product presentation and destination market<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Note:<\/strong> Always follow the current approved product information for the specific Tislelizumab product being supplied.<\/p>","protected":false},"excerpt":{"rendered":"

    Tislelizumab Injection<\/h1>\n
      \n
    • API:<\/strong> Tislelizumab<\/li>\n
    • Packaging:<\/strong> 100 mg\/10 mL vial<\/li>\n
    • Strength:<\/strong> 100 mg\/10 mL<\/li>\n
    • Dosage Form:<\/strong> Concentrate for solution for infusion<\/li>\n
    • Route:<\/strong> Intravenous infusion<\/li>\n
    • Therapeutic Area:<\/strong> Oncology<\/li>\n<\/ul>\n

      Note:<\/strong> Tislelizumab is a prescription medicine and should be used only under the supervision of a qualified healthcare professional.<\/p>","protected":false},"featured_media":6134,"template":"","meta":[],"product_brand":[],"product_cat":[18],"product_tag":[1114,1117,1113,1115,1116],"class_list":["post-6129","product","type-product","status-publish","has-post-thumbnail","product_cat-oncology","product_tag-cancer-treatment","product_tag-immunotherapy","product_tag-oncology-medicines","product_tag-pd-1-inhibitor","product_tag-tislelizumab-injection","first","instock","shipping-taxable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/product\/6129","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/media\/6134"}],"wp:attachment":[{"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/media?parent=6129"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/product_brand?post=6129"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/product_cat?post=6129"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indiangenericmedicines.com\/zh\/wp-json\/wp\/v2\/product_tag?post=6129"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}